Back

Impact of SGLT-2 inhibitors on ventricular arrhythmias and cardiovascular mortality in patients with heart failure and ICD or CRT devices: a systematic review and meta-analysis

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Risk Factors and risk assessment: heart failure and sudden cardiac death Risk Factors and Risk Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Rohan Goswami

Mayo Clinic, Jacksonville (United States of America)

5 More presentations in this session

Presentation thumbnail
Refining risk stratification for ventricular arrhythmias in patients with desmoplakin cardiomyopathy
Doctor A. Apostu (Bucharest, RO)
Abstract
Presentation thumbnail
Increased risk for major cardiac electrical events in patients with sarcoidosis: a nationwide cohort study
Doctor M. Murninkas (Ramat Gan, IL)
Abstract
Presentation thumbnail
Association of residual pulmonary hypertension with sudden cardiac death after hospitalisation for acute decompensated heart failure
Doctor T. Tamura (Tokyo, JP)
Abstract
Presentation thumbnail
A practical nomogram incorporating frontal QRS-T angle and aldosterone for early identification of cardiac sarcoidosis
Doctor N. Tripyla (Attica, GR)
Abstract
Presentation thumbnail
Without genetic testing, 1 in 4 DCM/NDLVC patients are wrongly risk-stratified in the current era of personalised care
Doctor D. Vlachomitros (Marousi, GR)
Abstract

Access the full session

Session thumbnail
Risk Factors and risk assessment: heart failure and sudden cardiac death

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of dapagliflozin on ventricular arrhythmic events in heart failure patients with implantable defibrillator.
12 May 2024
thumbnail
Congress Presentation
The benefits of adding a defibrillator to cardiac resynchronization therapy - systematic review and meta-analysis
23 May 2022
thumbnail
Congress Presentation
Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis
27 August 2021
thumbnail
Congress Presentation
Comparative effectiveness of pharmacologic agents for heart failure prevention in post-myocardial infarction patients: A comprehensive Bayesian network meta-analysis
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources